IXICO (LSE:IXI) Common Stock: £0.93 Mil (As of Mar. 2026)


What is IXICO Common Stock?

IXICO LSE:IXI -0.60% Common Stock is £0.93 Mil as of Mar. 2026. The stock has 2 warning signs investors should review.

IXICO's quarterly common stock stayed the same from Mar. 2025 (£0.93 Mil) to Sep. 2025 (£0.93 Mil) and stayed the same from Sep. 2025 (£0.93 Mil) to Mar. 2026 (£0.93 Mil).

IXICO's annual common stock stayed the same from Sep. 2023 (£0.48 Mil) to Sep. 2024 (£0.48 Mil) but then increased from Sep. 2024 (£0.48 Mil) to Sep. 2025 (£0.93 Mil).

IXICO Common Stock Historical Data

* Premium members only.

The historical data trend for IXICO's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IXICO Common Stock Chart

IXICO Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.48 0.48 0.48 0.93

IXICO Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.48 0.93 0.93 0.93

IXICO Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of £0.93 Mil mean?
IXICO (LSE:IXI) has a Common Stock of £0.93 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on IXICO and its competitors.
Is IXICO's Common Stock too high?
IXICO's current Common Stock is £0.93 Mil.
How does IXICO's Common Stock compare to VRTX and REGN?
IXICO's Common Stock of £0.93 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on IXICO and its competitors. IXICO's current Common Stock is £0.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IXICO stock overvalued right now?
Based on GuruFocus' analysis, IXICO (LSE:IXI) is currently considered Fairly Valued. The stock's GF Value™ is £0.08, compared to a current price of £0.08 — trading 3.1% above its estimated fair value. The current Common Stock is £0.93 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For IXICO (LSE:IXI), the current Common Stock is £0.93 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IXICO Business Description

Address 15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
IXICO PLC provides neuroscience imaging and biomarker analytics services, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. It operates as an imaging contract research organization, supporting clinical trials for neurological disorders by processing and analyzing imaging data. Its platform is used to measure biomarkers associated with diseases such as Alzheimer's, Huntington's, and Parkinson's.